Trial Profile
Phase I safety, tolerability and pharmacokinetics of WCK 771 800mg multiple dose intravenous infusion
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Levonadifloxacin (Primary)
- Indications Bacterial infections; Gram-positive infections; Staphylococcal infections
- Focus Adverse reactions
- Sponsors Wockhardt
- 05 Nov 2010 New trial record.